Direct Target Site Identification of a Sulfonyl-Triazole Covalent Kinase Probe by LC-MS Chemical Proteomics.
Rebecca L McCloudKun YuanKeira E MahoneyDina L BaiJeffrey ShabanowitzMark M RossDonald F HuntKu-Lung HsuPublished in: Analytical chemistry (2021)
Chemical proteomics is widely used for the global investigation of protein activity and binding of small molecule ligands. Covalent probe binding and inhibition are assessed using liquid chromatography-tandem mass spectrometry (LC-MS/MS) to gain molecular information on targeted proteins and probe-modified sites. The identification of amino acid sites modified by large complex probes, however, is particularly challenging because of the increased size, hydrophobicity, and charge state of peptides derived from modified proteins. These studies are important for direct evaluation of proteome-wide selectivity of inhibitor scaffolds used to develop targeted covalent inhibitors. Here, we disclose reverse-phase chromatography and MS dissociation conditions tailored for binding site identification using a clickable covalent kinase inhibitor containing a sulfonyl-triazole reactive group (KY-26). We applied this LC-MS/MS strategy to identify tyrosine and lysine sites modified by KY-26 in functional sites of kinases and other ATP-/NAD-binding proteins (>65 in total) in live cells. Our studies revealed key bioanalytical conditions to guide future chemical proteomic workflows for direct target site identification of complex irreversible probes and inhibitors.
Keyphrases
- small molecule
- mass spectrometry
- amino acid
- living cells
- liquid chromatography tandem mass spectrometry
- bioinformatics analysis
- single molecule
- induced apoptosis
- ms ms
- quantum dots
- cancer therapy
- healthcare
- label free
- fluorescence imaging
- binding protein
- simultaneous determination
- liquid chromatography
- oxidative stress
- cell death
- cell proliferation
- endoplasmic reticulum stress
- drug delivery
- high speed
- transcription factor
- current status
- protein kinase
- dna binding
- photodynamic therapy
- signaling pathway